Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Phyllis Jean Kanki, D.Sc., D.V.M.

Title
Institution
Department
Address
Phone
Profile Picture

Biography
University of Minnesota School of Veterinary MedicineD.V.M. 1982
Harvard School of Public HealthD.Sc.1985

Overview
My research centers on the virology, pathogenesis and molecular epidemiology of HIV in Africa. Based on long term research collaborations in Senegal for over 24 years, our work provided the initial characterization of HIV-2, demonstrated reduced virulence, transmission and progression to disease and interactions with HIV-1 subtypes from West Africa. In 2000, I created and directed the AIDS Prevention Initiative in Nigeria (APIN), with a $25 million grant from the Bill & Melinda Gates Foundation. This provided the collaborative foundation for the Harvard President's Emergency Plan for AIDS Relief (PEPFAR) providing prevention, care and HIV antiretroviral therapy in Nigeria, Botswana, and Tanzania (2004-2012). To date, in addition to the capacity building for clinical, laboratory and research capabilities, the program supported treatment for over 150,000 AIDS patients. The PEPFAR program in Nigeria has developed an extensive electronic medical record system that provides real time access to 250,000 patients on antiretroviral treatment in the country. These databases allow us to promote better clinical care and also to answer operational research questions dealing with the efficacy of ART and prevention of mother to child transmission (PMTCT) interventions and modulators of this response. Our operational research deals with HIV diversity and drug resistance, ART adherence and HIV co-infections including tuberculosis and hepatitis infections. Training has been a critical goal of this program and topics have included clinical ART for adults and children, principles of research ethics, laboratory methods, pharmacy, data management and analysis. We have built the capacity of over 22 laboratories in Nigerian teaching hospitals and research institutes to provide state of the art HIV diagnosis and monitoring.

My long-term research collaborations in West Africa have also incorporated training and research capacity building. I served as the Co-PI of the Harvard School of Public Health AITRIP (1988-2013). In 2010, the University of Ibadan, Nigeria, received a NIH Medical Education Partnership Initiative (MEPI) award from the Fogarty International Center and I currently lead the Harvard component of this consortium that promotes research capacity at three partner medical schools. The MEPI programs at the Universities of Ibadan, Jos and Lagos seek to enhance research capacity for junior faculty and to increase recruitment and retention of health professionals and academic faculty.

I am a visiting faculty member at the University of Ibadan and University of Jos in Nigeria.

In response to the recent epidemics of Ebola and Zika virus, we have documented the presence of ZIKV infection in Senegalese and Nigerian fever patients over ~ 25 years, demonstrating the endemicity of this unique arbovirus in the region. We have described the longevity, specificity and cross reactivity of T cell responses to ZIKV and DENV NS3. Ebola fusion proteins were used to characterize the T cell responses in exposed and surviving EBOV subjects. We are currently conducting an NIH funded study on the impact of Zika virus infection on pregnancy outcomes in Nigeria.

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R21AI137840 (KANKI, PHYLLIS J.) Dec 21, 2018 - Nov 30, 2020
    NIH/NIAID
    Zika Virus in Pregnancy in Nigeria
    Role: Principal Investigator
  2. U01GH002109 (AGBAJI, OCHE OCHAI) Sep 30, 2016 - Sep 29, 2021
    CDC/CGH
    Reaching 90% target of HIV viral suppression: The role of point of care VL monitoring in resources constrained settings
    Role: Co-Principal Investigator
  3. T32AI049928 (WIRTH, DYANN F) Jul 1, 2001 - Jun 30, 2007
    NIH/NIAID
    The Graduate Program in Tropical Infectious Diseases (GPiTID)
    Role: Principal Investigator
  4. R01AI046187 (KANKI, PHYLLIS J.) May 15, 2000 - Apr 30, 2005
    NIH/NIAID
    CORRELATES OF HIV-1 PROTECTION
    Role: Principal Investigator
  5. R01AI046274 (KANKI, PHYLLIS J.) Sep 30, 1999 - Sep 29, 2004
    NIH/NIAID
    HIV-2 CELLULAR IMMUNITY CROSS-REACTIVE WITH HIV-1
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Koofhethile CK, Moyo S, Kotokwe KP, Chang C, Mokgethi P, Muchoba L, Mokgweetsi S, Makhema J, Lockman S, Gaseitsiwe S, de Oliveira T, Essex M, Shapiro R, Kanki P, Novitsky V. Detection of Inducible Replication-Competent HIV-1 Subtype C Provirus Despite Long-Term Antiretroviral Treatment in Perinatally Infected Adolescents in Botswana. AIDS Res Hum Retroviruses. 2020 Oct 19. PMID: 32935556.
    Citations:    Fields:    
  2. Ogbenna AA, Meloni S, Inzaule S, Hamers RL, Sigaloff K, Osibogun A, Adeyemo TA, Okonkwo P, Samuels JO, Kanki PJ, Rinke de Wit TF, Akanmu AS. The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation. PLoS One. 2020; 15(8):e0238027. PMID: 32841264.
    Citations:    Fields:    
  3. Meloni ST, Agaba P, Chang CA, Yiltok E, Oguche S, Ejeliogu E, Agbaji O, Okonkwo P, Kanki PJ. Longitudinal evaluation of adherence, retention, and transition patterns of adolescents living with HIV in Nigeria. PLoS One. 2020; 15(7):e0236801. PMID: 32735566.
    Citations:    Fields:    Translation:Humans
  4. Ogunsola FT, Odukoya OO, Banigbe B, Caleb-Adepoju SO, Folarin O, Afolabi BB, Okubadejo NU, Adeyemo WL, Akanmu AS, Osuntoki A, Okonkwo P, Murphy R, Kanki P. A preprogram appraisal of factors influencing research productivity among faculty at college of medicine, University of Lagos. Ann Afr Med. 2020 Apr-Jun; 19(2):124-130. PMID: 32499469.
    Citations:    Fields:    Translation:Humans
  5. Nazziwa J, Faria NR, Chaplin B, Rawizza H, Kanki P, Dakum P, Abimiku A, Charurat M, Ndembi N, Esbjörnsson J. Characterisation of HIV-1 Molecular Epidemiology in Nigeria: Origin, Diversity, Demography and Geographic Spread. Sci Rep. 2020 02 26; 10(1):3468. PMID: 32103028.
    Citations:    Fields:    
  6. Onwuamah CK, Okpokwu J, Audu R, Imade G, Meloni ST, Okwuraiwe A, Chebu P, Musa AZ, Chaplin B, Dalhatu I, Agbaji O, Samuels J, Ezechi O, Ahmed M, Odaibo G, Olaleye DO, Okonkwo P, Salako BL, Raizes E, Yang C, Kanki PJ, Idigbe EO. Low levels of HIV-1 drug resistance mutations in patients who achieved viral re-suppression without regimen switch: a retrospective study. BMC Microbiol. 2020 01 20; 20(1):17. PMID: 31959116.
    Citations:    Fields:    
  7. Koofhethile CK, Moyo S, Kotokwe KP, Mokgethi P, Muchoba L, Mokgweetsi S, Gaolathe T, Makhema J, Shapiro R, Lockman S, Kanki P, Essex M, Gaseitsiwe S, de Oliveira T, Novitsky V. Undetectable proviral deoxyribonucleic acid in an adolescent perinatally infected with human immunodeficiency virus-1C and on long-term antiretroviral therapy resulted in viral rebound following antiretroviral therapy termination: A case report with implications for clinical care. Medicine (Baltimore). 2019 Nov; 98(47):e18014. PMID: 31764816.
    Citations:    Fields:    Translation:HumansCells
  8. Rawizza HE, Darin KM, Oladokun R, Brown B, Ogunbosi B, David N, Akanmu S, Olaitan O, Chang C, Scarsi KK, Okonkwo P, Kanki PJ. Safety and efficacy of rifabutin among HIV/TB-coinfected children on lopinavir/ritonavir-based ART. J Antimicrob Chemother. 2019 09 01; 74(9):2707-2715. PMID: 31139825.
    Citations:    Fields:    Translation:Humans
  9. Balogun M, Meloni ST, Igwilo UU, Roberts A, Okafor I, Sekoni A, Ogunsola F, Kanki PJ, Akanmu S. Status of HIV-infected patients classified as lost to follow up from a large antiretroviral program in southwest Nigeria. PLoS One. 2019; 14(7):e0219903. PMID: 31344057.
    Citations:    Fields:    Translation:Humans
  10. Meloni ST, Agbaji O, Chang CA, Agaba P, Imade G, Oguche S, Mukhtar A, Mitruka K, Cox MH, Zee A, Kanki P. The role of point-of-care viral load monitoring in achieving the target of 90% suppression in HIV-infected patients in Nigeria: study protocol for a randomized controlled trial. BMC Infect Dis. 2019 May 02; 19(1):368. PMID: 31046695.
    Citations:    Fields:    Translation:HumansCells
  11. Balogun MR, Sekoni AO, Meloni ST, Odukoya OO, Onajole AT, Longe-Peters OA, Ogunsola FT, Kanki PJ. Predictors of tuberculosis knowledge, attitudes and practices in urban slums in Nigeria: a cross-sectional study. Pan Afr Med J. 2019; 32:60. PMID: 31223352.
    Citations: 3     Fields:    Translation:Humans
  12. Agbaji OO, Abah IO, Ebonyi AO, Gimba ZM, Abene EE, Gomerep SS, Falang KD, Anejo-Okopi J, Agaba PA, Ugoagwu PO, Agaba EI, Imade GE, Sagay AS, Okonkwo P, Idoko JA, Kanki PJ. Long Term Exposure to Tenofovir Disoproxil Fumarate-Containing Antiretroviral Therapy Is Associated with Renal Impairment in an African Cohort of HIV-Infected Adults. J Int Assoc Provid AIDS Care. 2019 Jan-Dec; 18:2325958218821963. PMID: 30672363.
    Citations:    Fields:    Translation:Humans
  13. Chaplin B, Akanmu AS, Inzaule SC, Samuels JO, Okonkwo P, Ilesanmi O, Adewole IFA, Asadu C, Khamofu H, Mpazanje R, Ndembi N, Odafe S, Sigaloff KCE, Ngige EN, Abatta EO, Akinbiyi G, Dakum P, Rinke de Wit TF, Kanki P. Association between HIV-1 subtype and drug resistance in Nigerian infants. J Antimicrob Chemother. 2019 01 01; 74(1):172-176. PMID: 30260417.
    Citations: 3     Fields:    Translation:HumansCells
  14. Okunade KS, John-Olabode S, Akinsola OJ, Akinajo O, Akanmu SA, Kanki PJ. Effects of selenium supplementation on pregnancy outcome and disease progression in HIV-infected pregnant women in Lagos, Nigeria: Study protocol for a randomised, double-blind, placebo-controlled trial. Medicine (Baltimore). 2019 Jan; 98(3):e12735. PMID: 30653086.
    Citations:    Fields:    Translation:HumansCells
  15. Herrera BB, Tsai WY, Brites C, Luz E, Pedroso C, Drexler JF, Wang WK, Kanki PJ. Erratum for Herrera et al., "T Cell Responses to Nonstructural Protein 3 Distinguish Infections by Dengue and Zika Viruses". mBio. 2018 10 23; 9(5). PMID: 30352936.
    Citations:    Fields:    
  16. Herrera BB, Tsai WY, Brites C, Luz E, Pedroso C, Drexler JF, Wang WK, Kanki PJ. T Cell Responses to Nonstructural Protein 3 Distinguish Infections by Dengue and Zika Viruses. mBio. 2018 08 07; 9(4). PMID: 30087165.
    Citations: 1     Fields:    Translation:HumansCells
  17. Nabi R, Kanki P, Shpitser I. Estimation of Personalized Effects Associated With Causal Pathways. Uncertain Artif Intell. 2018 Aug; 2018. PMID: 30643490.
    Citations: 1     
  18. Herrera BB, Hamel DJ, Oshun P, Akinsola R, Akanmu AS, Chang CA, Eromon P, Folarin O, Adeyemi KT, Happi CT, Lu Y, Ogunsola F, Kanki PJ. A modified anthrax toxin-based enzyme-linked immunospot assay reveals robust T cell responses in symptomatic and asymptomatic Ebola virus exposed individuals. PLoS Negl Trop Dis. 2018 05; 12(5):e0006530. PMID: 29795572.
    Citations: 1     Fields:    Translation:HumansCells
  19. Herrera BB, Tsai WY, Chang CA, Hamel DJ, Wang WK, Lu Y, Mboup S, Kanki PJ. Sustained Specific and Cross-Reactive T Cell Responses to Zika and Dengue Virus NS3 in West Africa. J Virol. 2018 04 01; 92(7). PMID: 29321308.
    Citations: 10     Fields:    Translation:HumansCells
  20. Agaba PA, Genberg BL, Sagay AS, Agbaji OO, Meloni ST, Dadem NY, Kolawole GO, Okonkwo P, Kanki PJ, Ware NC. Retention in Differentiated Care: Multiple Measures Analysis for a Decentralized HIV Care and Treatment Program in North Central Nigeria. J AIDS Clin Res. 2018; 9(2). PMID: 29682399.
    Citations:    
  21. Miles CH, Shpitser I, Kanki P, Meloni S, Tchetgen EJT. Quantifying an Adherence Path-Specific Effect of Antiretroviral Therapy in the Nigeria PEPFAR Program. J Am Stat Assoc. 2017; 112(520):1443-1452. PMID: 32042214.
    Citations: 1     
  22. Abah IO, Ncube NBQ, Bradley HA, AgbaJi OO, Kanki P. Antiretroviral Therapy-associated Adverse Drug Reactions and their Effects on Virologic Failure- A Retrospective Cohort Study in Nigeria. Curr HIV Res. 2018; 16(6):436-446. PMID: 30767743.
    Citations: 1     Fields:    Translation:Humans
  23. Chaplin B, Imade G, Onwuamah C, Odaibo G, Audu R, Okpokwu J, Olaleye D, Meloni S, Rawizza H, Muazu M, Musa AZ, Samuel J, Agbaji O, Ezechi O, Idigbe E, Kanki PJ. Distinct Pattern of Thymidine Analogue Mutations with K65R in Patients Failing Tenofovir-Based Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2018 02; 34(2):228-233. PMID: 29084434.
    Citations:    Fields:    Translation:HumansCells
  24. Meloni ST, Onwuamah CK, Agbaji O, Chaplin B, Olaleye DO, Audu R, Samuels J, Ezechi O, Imade G, Musa AZ, Odaibo G, Okpokwu J, Rawizza H, Mu'azu MA, Dalhatu I, Ahmed M, Okonkwo P, Raizes E, Ujah IAO, Yang C, Idigbe EO, Kanki PJ. Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options. Open Forum Infect Dis. 2017; 4(4):ofx233. PMID: 29255731.
    Citations: 1     
  25. Meloni ST, Chaplin B, Idoko J, Agbaji O, Akanmu S, Imade G, Okonkwo P, Murphy RL, Kanki PJ. Drug resistance patterns following pharmacy stock shortage in Nigerian Antiretroviral Treatment Program. AIDS Res Ther. 2017 Oct 13; 14(1):58. PMID: 29029637.
    Citations: 5     Fields:    Translation:HumansCells
  26. Agaba P, Meloni S, Sule H, Ocheke A, Agaba E, Idoko J, Kanki P. Factors associated with early menopause among women in Nigeria. J Virus Erad. 2017 Jul 01; 3(3):145-151. PMID: 28758022.
    Citations:    
  27. Herrera BB, Chang CA, Hamel DJ, Mboup S, Ndiaye D, Imade G, Okpokwu J, Agbaji O, Bei AK, Kanki PJ. Continued Transmission of Zika Virus in Humans in West Africa, 1992-2016. J Infect Dis. 2017 05 15; 215(10):1546-1550. PMID: 28398562.
    Citations: 15     Fields:    Translation:HumansCells
  28. Agaba PA, Meloni ST, Sule HM, Ocheke AN, Agaba EI, Idoko JA, Kanki PJ. Prevalence and predictors of severe menopause symptoms among HIV-positive and -negative Nigerian women. Int J STD AIDS. 2017 11; 28(13):1325-1334. PMID: 28409538.
    Citations:    Fields:    Translation:Humans
  29. Agaba PA, Meloni ST, Sule HM, Agaba EI, Idoko JA, Kanki PJ. Sexual dysfunction and its determinants among women infected with HIV. Int J Gynaecol Obstet. 2017 Jun; 137(3):301-308. PMID: 28273350.
    Citations:    Fields:    Translation:Humans
  30. Rhee SY, Varghese V, Holmes SP, Van Zyl GU, Steegen K, Boyd MA, Cooper DA, Nsanzimana S, Saravanan S, Charpentier C, de Oliveira T, Etiebet MA, Garcia F, Goedhals D, Gomes P, Günthard HF, Hamers RL, Hoffmann CJ, Hunt G, Jiamsakul A, Kaleebu P, Kanki P, Kantor R, Kerschberger B, Marconi VC, D'amour Ndahimana J, Ndembi N, Ngo-Giang-Huong N, Rokx C, Santoro MM, Schapiro JM, Schmidt D, Seu L, Sigaloff KCE, Sirivichayakul S, Skhosana L, Sunpath H, Tang M, Yang C, Carmona S, Gupta RK, Shafer RW. Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration. EBioMedicine. 2017 Apr; 18:225-235. PMID: 28365230.
    Citations: 13     Fields:    Translation:HumansCells
  31. Agaba PA, Meloni ST, Sule HM, Agbaji OO, Sagay AS, Okonkwo P, Idoko JA, Kanki PJ. Treatment Outcomes Among Older Human Immunodeficiency Virus-Infected Adults in Nigeria. Open Forum Infect Dis. 2017; 4(2):ofx031. PMID: 29497627.
    Citations: 3     
  32. Ebonyi AO, Oguche S, Agbaji OO, Sagay AS, Okonkwo PI, Idoko JA, Kanki PJ. Mortality among pulmonary tuberculosis and HIV-1 co-infected Nigerian children being treated for pulmonary tuberculosis and on antiretroviral therapy: a retrospective cohort study. Germs. 2016 12; 6(4):139-150. PMID: 28053917.
    Citations: 1     
  33. Gregson J, Kaleebu P, Marconi VC, van Vuuren C, Ndembi N, Hamers RL, Kanki P, Hoffmann CJ, Lockman S, Pillay D, de Oliveira T, Clumeck N, Hunt G, Kerschberger B, Shafer RW, Yang C, Raizes E, Kantor R, Gupta RK. Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study. Lancet Infect Dis. 2017 03; 17(3):296-304. PMID: 27914856.
    Citations: 18     Fields:    Translation:HumansCells
  34. Meloni ST, Chang CA, Eisen G, Jolayemi T, Banigbe B, Okonkwo PI, Kanki PJ. Long-Term Outcomes on Antiretroviral Therapy in a Large Scale-Up Program in Nigeria. PLoS One. 2016; 11(10):e0164030. PMID: 27764094.
    Citations: 9     Fields:    Translation:Humans
  35. Ebonyi AO, Oguche S, Ejeliogu EU, Agbaji OO, Shehu NY, Abah IO, Sagay AS, Ugoagwu PO, Okonkwo PI, Idoko JA, Kanki PJ. Prevalence of and risk factors for pulmonary tuberculosis among newly diagnosed HIV-1 infected Nigerian children. Germs. 2016 Mar; 6(1):21-8. PMID: 27019829.
    Citations: 2     
  36. Scarsi KK, Eisen G, Darin KM, Meloni ST, Rawizza HE, Tchetgen Tchetgen EJ, Agbaji OO, Onwujekwe DI, Gashau W, Nkado R, Okonkwo P, Murphy RL, Kanki PJ. Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian Cohort. Clin Infect Dis. 2016 Feb 15; 62(4):512-8. PMID: 26561532.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  37. Chang CA, Meloni ST, Eisen G, Chaplin B, Akande P, Okonkwo P, Rawizza HE, Tchetgen Tchetgen E, Kanki PJ. Tuberculosis Incidence and Risk Factors Among Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy in a Large HIV Program in Nigeria. Open Forum Infect Dis. 2015 Dec; 2(4):ofv154. PMID: 26613097.
    Citations: 4     
  38. Abah IO, Akanbi M, Abah ME, Finangwai AI, Dady CW, Falang KD, Ebonyi AO, Okopi JA, Agbaji OO, Sagay AS, Okonkwo P, Idoko JA, Kanki PJ. Incidence and predictors of adverse drug events in an African cohort of HIV-infected adults treated with efavirenz. Germs. 2015 Sep; 5(3):83-91. PMID: 26405676.
    Citations: 6     
  39. Hamel DJ, Sankalé JL, Samuels JO, Sarr AD, Chaplin B, Ofuche E, Meloni ST, Okonkwo P, Kanki PJ. Building laboratory capacity to support HIV care in Nigeria: Harvard/APIN PEPFAR, 2004-2012. Afr J Lab Med. 2015; 4(1). PMID: 26900573.
    Citations: 6     
  40. Abah IO, Darin KM, Ebonyi AO, Ugoagwu P, Ojeh VB, Nasir N, Falang KD, Olaitan O, Agbaji O, Idoko J, Kanki P. Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in Nigeria. J Int Assoc Provid AIDS Care. 2015 Jul-Aug; 14(4):348-54. PMID: 25566781.
    Citations: 3     Fields:    Translation:HumansCells
  41. Kanki PJ. Editorial: Programmatic Evaluation of HIV Prevention and Treatment in Nigeria. Curr HIV Res. 2015; 13(3):174-5. PMID: 25986367.
    Citations:    Fields:    Translation:Humans
  42. Sagay AS, Ebonyi AO, Meloni ST, Musa J, Oguche S, Ekwempu CC, Oyebode T, Ejeliogu E, Imade GE, Agbaji OO, Okonkwo P, Kanki PJ. Mother-to-Child Transmission Outcomes of HIV-Exposed Infants Followed Up in Jos North-Central Nigeria. Curr HIV Res. 2015; 13(3):193-200. PMID: 25986370.
    Citations: 5     Fields:    Translation:Humans
  43. Agbaji OO, Abah IO, Falang KD, Ebonyi AO, Musa J, Ugoagwu P, Agaba PA, Sagay AS, Jolayemi T, Okonkwo P, Idoko JA, Kanki PJ. Treatment Discontinuation in Adult HIV-Infected Patients on First-Line Antiretroviral Therapy in Nigeria. Curr HIV Res. 2015; 13(3):184-92. PMID: 25986369.
    Citations: 2     Fields:    Translation:Humans
  44. Meloni ST, Chaplin B, Chang C, Rawizza H, Okonkwo P, Kanki PJ. Patterns of Adherence and Loss to Follow-Up in Pediatric Patients on ART in Nigeria. Curr HIV Res. 2015; 13(3):210-8. PMID: 25986372.
    Citations: 3     Fields:    Translation:Humans
  45. Akanmu AS, Adeyemo T, Lesi F, Bello FO, Okwuegbuna K, Oloko K, Awolola A, Ogunsola FT, Okonkwo P, Kanki PJ. Immunological and Virological Outcomes of Patients Switched from LPV/r to ATV/r-Containing Second- Line Regimens. Curr HIV Res. 2015; 13(3):176-83. PMID: 25986368.
    Citations: 3     Fields:    Translation:Humans
  46. Rawizza HE, Chang CA, Chaplin B, Ahmed IA, Meloni ST, Oyebode T, Banigbe B, Sagay AS, Adewole IF, Okonkwo P, Kanki PJ. Loss to Follow-Up within the Prevention of Mother-to-Child Transmission Care Cascade in a Large ART Program in Nigeria. Curr HIV Res. 2015; 13(3):201-9. PMID: 25986371.
    Citations: 15     Fields:    Translation:Humans
  47. Ebonyi AO, Oguche S, Meloni ST, Sagay SA, Kyriacou DN, Achenbach CJ, Agbaji OO, Oyebode TA, Okonkwo P, Idoko JA, Kanki PJ. Predictors of Mortality in a Clinic Cohort of HIV-1 Infected Children Initiated on Antiretroviral Therapy in Jos, Nigeria. J AIDS Clin Res. 2014; 5(12). PMID: 30416842.
    Citations: 1     
  48. Balogun M, Sekoni A, Meloni ST, Odukoya O, Onajole A, Longe-Peters O, Ogunsola F, Kanki PJ. Trained community volunteers improve tuberculosis knowledge and attitudes among adults in a periurban community in southwest Nigeria. Am J Trop Med Hyg. 2015 Mar; 92(3):625-32. PMID: 25510722.
    Citations: 5     Fields:    Translation:Humans
  49. Musa J, Achenbach C, Taiwo B, Berzins B, Silas O, Daru PH, Agbaji O, Imade G, Sagay AS, Idoko JA, Kanki PJ, Murphy RL. High-risk human papilloma virus and cervical abnormalities in HIV-infected women with normal cervical cytology. Infect Agent Cancer. 2014; 9(1):36. PMID: 25395987.
    Citations: 1     
  50. Kuti MA, Adesina OA, Awolude OA, Ogunbosi BO, Fayemiwo SA, Akinyemi JO, Adetunji AA, Irabor AE, Odaibo GN, Prosper O, Taiwo BO, Olaleye D, Murphy RL, Kanki P, Adewole IF. Dyslipidemia in ART-Naive HIV-Infected Persons in Nigeria--Implications for Care. J Int Assoc Provid AIDS Care. 2015 Jul-Aug; 14(4):355-9. PMID: 25331224.
    Citations: 5     Fields:    Translation:Humans
  51. Chaplin B, Meloni S, Eisen G, Jolayemi T, Banigbe B, Adeola J, Wen C, Reyes Nieva H, Chang C, Okonkwo P, Kanki P. Scale-up of networked HIV treatment in Nigeria: creation of an integrated electronic medical records system. Int J Med Inform. 2015 Jan; 84(1):58-68. PMID: 25301692.
    Citations: 15     Fields:    Translation:HumansCells
  52. Imade GE, Musa J, Sagay AS, Kapiga SH, Sankale JL, Idoko J, Kanki P. Association of Bacterial vaginosis and other Sexually Transmitted Infections with HIV among pregnant women in Nigeria. Afr J Med Med Sci. 2014 Sep; 43(Suppl 1):23-28. PMID: 26681823.
    Citations:    Fields:    
  53. Meloni ST, Chang C, Chaplin B, Rawizza H, Jolayemi O, Banigbe B, Okonkwo P, Kanki P. Time-Dependent Predictors of Loss to Follow-Up in a Large HIV Treatment Cohort in Nigeria. Open Forum Infect Dis. 2014 Sep; 1(2):ofu055. PMID: 25734125.
    Citations: 20     
  54. Olaleye DO, Odaibo GN, Carney P, Agbaji O, Sagay AS, Muktar H, Akinyinka OO, Omigbodun AO, Ogunniyi A, Gashau W, Akanmu S, Ogunsola F, Chukwuka C, Okonkwo PI, Meloni ST, Adewole I, Kanki PJ, Murphy RL. Enhancement of health research capacity in Nigeria through north-south and in-country partnerships. Acad Med. 2014 Aug; 89(8 Suppl):S93-7. PMID: 25072590.
    Citations: 10     Fields:    Translation:Humans
  55. Okonkwo P, Sagay AS, Agaba PA, Yohanna S, Agbaji OO, Imade GE, Banigbe B, Adeola J, Oyebode TA, Idoko JA, Kanki PJ. Treatment outcomes in a decentralized antiretroviral therapy program: a comparison of two levels of care in north central Nigeria. AIDS Res Treat. 2014; 2014:560623. PMID: 25028610.
    Citations: 1     
  56. Kanki PJ, Rowland-Jones S. The protective effect of HIV-2 infection: implications for understanding HIV-1 immunity. AIDS. 2014 Apr 24; 28(7):1065-7. PMID: 24685743.
    Citations: 1     Fields:    Translation:HumansCells
  57. Agaba PA, Meloni ST, Sule HM, Agbaji OO, Ekeh PN, Job GC, Nyango N, Ugoagwu PO, Imade GE, Idoko JA, Kanki PJ. Patients who present late to HIV care and associated risk factors in Nigeria. HIV Med. 2014 Aug; 15(7):396-405. PMID: 24580742.
    Citations: 12     Fields:    Translation:Humans
  58. Imade GE, Sagay AS, Musa J, Ocheke AN, Adeniyi DS, Idighri M, Powl R, Sendeht A, Ogwuche JP, Elujoba M, Egbodo CO, Oyebode T, Daru PH, Agbaji O, Pam IC, Meloni ST, Okonkwo P, Kanki PJ. Declining rate of infection with maternal human immunodeficiency virus at delivery units in north-central Nigeria. Afr J Reprod Health. 2013 Dec; 17(4 Spec No):138-45. PMID: 24689325.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  59. Imade GE, Sagay AS, Chaplin B, Chebu P, Musa J, Okpokwu J, Hamel DJ, Pam IC, Agbaji O, Samuels J, Meloni S, Sankale JL, Okonkwo P, Kanki P. Short communication: Transmitted HIV drug resistance in antiretroviral-naive pregnant women in north central Nigeria. AIDS Res Hum Retroviruses. 2014 Feb; 30(2):127-33. PMID: 24164431.
    Citations: 13     Fields:    Translation:HumansCells
  60. Rawizza HE, Chaplin B, Meloni ST, Darin KM, Olaitan O, Scarsi KK, Onwuamah CK, Audu RA, Chebu PR, Imade GE, Okonkwo P, Kanki PJ. Accumulation of protease mutations among patients failing second-line antiretroviral therapy and response to salvage therapy in Nigeria. PLoS One. 2013; 8(9):e73582. PMID: 24069209.
    Citations: 17     Fields:    Translation:HumansCells
  61. Ladep NG, Agbaji OO, Agaba PA, Muazu A, Ugoagwu P, Imade G, Cooke GS, Vivas L, Cormack SM, Taylor-Robinson SD, Idoko J, Kanki P. Hepatitis B Co-Infection is Associated with Poorer Survival of HIV-Infected Patients on Highly Active Antiretroviral Therapy in West Africa. J AIDS Clin Res. 2013 Jun 29; Suppl 3. PMID: 25328814.
    Citations: 4     
  62. Tang MW, Rhee SY, Bertagnolio S, Ford N, Holmes S, Sigaloff KC, Hamers RL, de Wit TF, Fleury HJ, Kanki PJ, Ruxrungtham K, Hawkins CA, Wallis CL, Stevens W, van Zyl GU, Manosuthi W, Hosseinipour MC, Ngo-Giang-Huong N, Belec L, Peeters M, Aghokeng A, Bunupuradah T, Burda S, Cane P, Cappelli G, Charpentier C, Dagnra AY, Deshpande AK, El-Katib Z, Eshleman SH, Fokam J, Gody JC, Katzenstein D, Koyalta DD, Kumwenda JJ, Lallemant M, Lynen L, Marconi VC, Margot NA, Moussa S, Ndung'u T, Nyambi PN, Orrell C, Schapiro JM, Schuurman R, Sirivichayakul S, Smith D, Zolfo M, Jordan MR, Shafer RW. Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine. J Infect Dis. 2013 Jun 15; 207 Suppl 2:S70-7. PMID: 23687292.
    Citations: 17     Fields:    Translation:HumansCells
  63. Dinic L, Idigbe OE, Meloni S, Rawizza H, Akande P, Eisen G, Onwujekwe D, Agbaji O, Ani A, Kanki PJ. Sputum smear concentration may misidentify acid-fast bacilli as Mycobacterium tuberculosis in HIV-infected patients. . 2013 Jun 01; 63(2):168-77. PMID: 23392466.
    Citations: 2     Translation:HumansCells
  64. Musa J, Taiwo B, Achenbach C, Olugbenga S, Berzins B, Sagay AS, Idoko JA, Kanki PJ, Murphy RL. High-risk human papillomavirus among HIV-infected women with normal cervical cytology: a pilot study in Jos, Nigeria. Arch Gynecol Obstet. 2013 Dec; 288(6):1365-70. PMID: 23700253.
    Citations: 4     Fields:    Translation:HumansCells
  65. Ladep NG, Agaba PA, Agbaji O, Muazu A, Ugoagwu P, Imade G, Cooke G, McCormack S, Taylor-Robinson SD, Idoko J, Kanki P. Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort. World J Gastroenterol. 2013 Mar 14; 19(10):1602-10. PMID: 23538773.
    Citations: 13     Fields:    Translation:HumansCells
  66. Falade CO, Adesina-Adewole B, Dada-Adegbola HO, Ajayi IO, Akinyemi JO, Ademowo OG, Adewole IF, Kanki P. Evaluation of Paracheck-Pf(TM) rapid malaria diagnostic test for the diagnosis of malaria among HIV-positive patients in Ibadan, south-western Nigeria. Pathog Glob Health. 2013 Mar; 107(2):69-77. PMID: 23683333.
    Citations: 6     Fields:    Translation:Humans
  67. Akanbi MO, Achenbach CJ, Feinglass J, Taiwo B, Onu A, Pho MT, Agbaji O, Kanki P, Murphy RL. Tuberculosis after one year of combination antiretroviral therapy in Nigeria: a retrospective cohort study. AIDS Res Hum Retroviruses. 2013 Jun; 29(6):931-7. PMID: 23316724.
    Citations: 9     Fields:    Translation:Humans
  68. Agbaji O, Thio CL, Meloni S, Graham C, Muazu M, Nimzing L, Idoko J, Sankalé JL, Ekong E, Murphy R, Kanki P, Hawkins C. Impact of hepatitis C virus on HIV response to antiretroviral therapy in Nigeria. . 2013 Feb 01; 62(2):204-7. PMID: 23196830.
    Citations: 1     Translation:HumansCells
  69. Kanki P, Kakkattil P, Simao M. Scaling up HIV treatment and prevention through national responses and innovative leadership. . 2012 Aug 01; 60 Suppl 2:S27-30. PMID: 22772386.
    Citations: 5     Translation:Humans
  70. Dinic L, Akande P, Idigbe EO, Ani A, Onwujekwe D, Agbaji O, Akanbi M, Nwosu R, Adeniyi B, Wahab M, Lekuk C, Kunle-Ope C, Nwokoye N, Kanki P. Genetic determinants of drug-resistant tuberculosis among HIV-infected patients in Nigeria. J Clin Microbiol. 2012 Sep; 50(9):2905-9. PMID: 22740709.
    Citations: 9     Fields:    Translation:HumansCells
  71. Tang MW, Kanki PJ, Shafer RW. A review of the virological efficacy of the 4 World Health Organization-recommended tenofovir-containing regimens for initial HIV therapy. Clin Infect Dis. 2012 Mar; 54(6):862-75. PMID: 22357809.
    Citations: 25     Fields:    Translation:Humans
  72. Rawizza HE, Chaplin B, Meloni ST, Eisen G, Rao T, Sankalé JL, Dieng-Sarr A, Agbaji O, Onwujekwe DI, Gashau W, Nkado R, Ekong E, Okonkwo P, Murphy RL, Kanki PJ. Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings. Clin Infect Dis. 2011 Dec; 53(12):1283-90. PMID: 22080121.
    Citations: 68     Fields:    Translation:Humans
  73. Agaba PA, Digin E, Makai R, Apena L, Agbaji OO, Idoko JA, Murphy R, Kanki P. Clinical characteristics and predictors of mortality in hospitalized HIV-infected Nigerians. J Infect Dev Ctries. 2011 May 28; 5(5):377-82. PMID: 21628815.
    Citations: 14     Fields:    Translation:Humans
  74. Brown BJ, Oladokun RE, Osinusi K, Ochigbo S, Adewole IF, Kanki P. Disclosure of HIV status to infected children in a Nigerian HIV Care Programme. AIDS Care. 2011 Sep; 23(9):1053-8. PMID: 21476150.
    Citations: 38     Fields:    Translation:Humans
  75. Agbaji OO, Agaba PA, Idoko JA, Taiwo B, Murphy R, Kanki P, Ekong E. Temporal changes in renal glomerular function associated with the use of Tenofovir Disoproxil Fumarate in HIV-infected Nigerians. West Afr J Med. 2011 May-Jun; 30(3):164-8. PMID: 22120479.
    Citations: 6     Fields:    Translation:HumansCells
  76. Brown BJ, Oladokun RE, Odaibo GN, Olaleye DO, Osinusi K, Kanki P. Clinical and Immunological Profile of Pediatric HIV Infection in Ibadan, Nigeria. J Int Assoc Physicians AIDS Care (Chic). 2011 Jan-Feb; 10(1):49-53. PMID: 21368015.
    Citations: 2     Fields:    Translation:Humans
  77. Chaplin B, Eisen G, Idoko J, Onwujekwe D, Idigbe E, Adewole I, Gashau W, Meloni S, Sarr AD, Sankalé JL, Ekong E, Murphy RL, Kanki P. Impact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapy. AIDS Res Hum Retroviruses. 2011 Jan; 27(1):71-80. PMID: 20964479.
    Citations: 14     Fields:    Translation:HumansCells
  78. Akinyemi JO, Awolude OA, Adewole IF, Kanki PJ. Condom use among antiretroviral therapy patients in Ibadan, Nigeria. J Infect Dev Ctries. 2010 Sep 03; 4(8):495-502. PMID: 20818101.
    Citations: 7     Fields:    Translation:Humans
  79. Oladokun RE, Awolude O, Brown BJ, Adesina O, Oladokun A, Roberts A, Odaibo G, Osinusi K, Olaleye D, Adewole IF, Kanki P. Service uptake and performance of the prevention of mother-to-child transmission (PMTCT) programme in Ibadan, Nigeria. Afr J Med Med Sci. 2010 Jun; 39(2):81-7. PMID: 21117403.
    Citations: 10     Fields:    Translation:Humans
  80. Taiwo B, Chaplin B, Penugonda S, Meloni S, Akanmu S, Gashau W, Idoko J, Adewole I, Murphy R, Kanki P. Suboptimal etravirine activity is common during failure of nevirapine-based combination antiretroviral therapy in a cohort infected with non-B subtype HIV-1. Curr HIV Res. 2010 Apr; 8(3):194-8. PMID: 20163340.
    Citations: 7     Fields:    Translation:HumansCells
  81. Idoko J, Meloni S, Muazu M, Nimzing L, Badung B, Hawkins C, Sankalé JL, Ekong E, Murphy R, Kanki P, Thio CL. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. Clin Infect Dis. 2009 Oct 15; 49(8):1268-73. PMID: 19772386.
    Citations: 39     Fields:    Translation:Humans
  82. Hawkins CA, Chaplin B, Idoko J, Ekong E, Adewole I, Gashau W, Murphy RL, Kanki P. Clinical and genotypic findings in HIV-infected patients with the K65R mutation failing first-line antiretroviral therapy in Nigeria. . 2009 Oct 01; 52(2):228-34. PMID: 19644383.
    Citations: 15     Translation:HumansCells
  83. Strong CL, Lanchy JM, Dieng-Sarr A, Kanki PJ, Lodmell JS. A 5'UTR-spliced mRNA isoform is specialized for enhanced HIV-2 gag translation. J Mol Biol. 2009 Aug 14; 391(2):426-37. PMID: 19559029.
    Citations: 8     Fields:    Translation:HumansAnimalsCells
  84. Agaba PA, Sule HM, Ojoh RO, Hassan Z, Apena L, Mu'azu MA, Badung B, Agbaji OO, Idoko JA, Kanki P. Presentation and survival of patients with AIDS-related Kaposi's sarcoma in Jos, Nigeria. Int J STD AIDS. 2009 Jun; 20(6):410-3. PMID: 19451327.
    Citations: 4     Fields:    Translation:Humans
  85. Ulenga NK, Sarr AD, Hamel D, Sankale JL, Mboup S, Kanki PJ. The level of APOBEC3G (hA3G)-related G-to-A mutations does not correlate with viral load in HIV type 1-infected individuals. AIDS Res Hum Retroviruses. 2008 Oct; 24(10):1285-90. PMID: 18851679.
    Citations: 21     Fields:    Translation:HumansAnimalsCells
  86. Ojesina AI, Chaplin B, Sankalé JL, Murphy R, Idigbe E, Adewole I, Ekong E, Idoko J, Kanki PJ. Interplay of reverse transcriptase inhibitor therapy and gag p6 diversity in HIV type 1 subtype G and CRF02_AG. AIDS Res Hum Retroviruses. 2008 Sep; 24(9):1167-74. PMID: 18729771.
    Citations: 2     Fields:    Translation:HumansCells
  87. Ulenga NK, Sarr AD, Thakore-Meloni S, Sankalé JL, Eisen G, Kanki PJ. Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F. J Infect Dis. 2008 Aug 15; 198(4):486-92. PMID: 18598197.
    Citations: 26     Fields:    Translation:HumansCells
  88. Otegbayo JA, Taiwo BO, Akingbola TS, Odaibo GN, Adedapo KS, Penugonda S, Adewole IF, Olaleye DO, Murphy R, Kanki P. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. Ann Hepatol. 2008 Apr-Jun; 7(2):152-6. PMID: 18626434.
    Citations: 32     Fields:    Translation:Humans
  89. Ojesina AI, Mullins C, Imade G, Samuels J, Sankalé JL, Pam S, Sagay S, Idoko J, Kanki PJ. Characterization of HIV type 1 reverse transcriptase mutations in infants infected by mothers who received peripartum nevirapine prophylaxis in Jos, Nigeria. AIDS Res Hum Retroviruses. 2007 Dec; 23(12):1587-92. PMID: 18160018.
    Citations: 3     Fields:    Translation:HumansCells
  90. Idoko JA, Agbaji O, Agaba P, Akolo C, Inuwa B, Hassan Z, Akintunde L, Badung B, Muazu M, Danang M, Imade G, Sankale JL, Kanki P. Direct observation therapy-highly active antiretroviral therapy in a resource-limited setting: the use of community treatment support can be effective. Int J STD AIDS. 2007 Nov; 18(11):760-3. PMID: 18005510.
    Citations: 13     Fields:    Translation:HumansCellsCTClinical Trials
  91. Hamel DJ, Sankalé JL, Eisen G, Meloni ST, Mullins C, Gueye-Ndiaye A, Mboup S, Kanki PJ. Twenty years of prospective molecular epidemiology in Senegal: changes in HIV diversity. AIDS Res Hum Retroviruses. 2007 Oct; 23(10):1189-96. PMID: 17961103.
    Citations: 22     Fields:    Translation:HumansCellsPHPublic Health
  92. Sankalé JL, Langevin S, Odaibo G, Meloni ST, Ojesina AI, Olaleye D, Kanki P. The complexity of circulating HIV type 1 strains in Oyo state, Nigeria. AIDS Res Hum Retroviruses. 2007 Aug; 23(8):1020-5. PMID: 17725419.
    Citations: 12     Fields:    Translation:HumansCells
  93. Ladep NG, Agbaji O, Agaba P, Badung P, Imade G, Sankalé J, Idoko J, Kanki P. Does immunological status affect the prevalence of Hepatitis C virus infection among HIV/AIDS patients? Niger J Med. 2007 Jul-Sep; 16(3):231-4. PMID: 17937159.
    Citations: 2     Fields:    Translation:Humans
  94. Sierra B, Alegre R, Pérez AB, García G, Sturn-Ramirez K, Obasanjo O, Aguirre E, Alvarez M, Rodriguez-Roche R, Valdés L, Kanki P, Guzmán MG. HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection. Hum Immunol. 2007 Jun; 68(6):531-40. PMID: 17509453.
    Citations: 35     Fields:    Translation:HumansCells
  95. MacNeil A, Sarr AD, Sankalé JL, Meloni ST, Mboup S, Kanki P. Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection. J Virol. 2007 May; 81(10):5325-30. PMID: 17329334.
    Citations: 38     Fields:    Translation:HumansCells
  96. Rodriguez SK, Sarr AD, MacNeil A, Thakore-Meloni S, Gueye-Ndiaye A, Traoré I, Dia MC, Mboup S, Kanki PJ. Comparison of heterologous neutralizing antibody responses of human immunodeficiency virus type 1 (HIV-1)- and HIV-2-infected Senegalese patients: distinct patterns of breadth and magnitude distinguish HIV-1 and HIV-2 infections. J Virol. 2007 May; 81(10):5331-8. PMID: 17301136.
    Citations: 20     Fields:    Translation:HumansCells
  97. MacNeil A, Sankale JL, Meloni ST, Sarr AD, Mboup S, Kanki P. Long-term intrapatient viral evolution during HIV-2 infection. J Infect Dis. 2007 Mar 01; 195(5):726-33. PMID: 17262716.
    Citations: 14     Fields:    Translation:HumansCells
  98. Ojesina AI, Kanki PJ. HIV-1 subtype and reverse transcriptase genotype: role for geographical location and founder effects. PLoS Med. 2006 Dec; 3(12):e540. PMID: 17194205.
    Citations: 2     Fields:    Translation:HumansCells
  99. Sagay AS, Musa J, Ekwempu CC, Imade GE, Babalola A, Daniyan G, Malu N, Idoko JA, Kanki P. Partner disclosure of HIV status among HIV positive mothers in Northern Nigeria. Afr J Med Med Sci. 2006 Dec; 35 Suppl:119-23. PMID: 18050785.
    Citations: 11     Fields:    Translation:Humans
  100. Rodriguez SK, Sarr AD, Olorunnipa O, Popper SJ, Gueye-Ndiaye A, Traoré I, Dia MC, Mboup S, Kanki PJ. The absence of anti-Tat antibodies is associated with risk of disease progression in HIV-2 infection. J Infect Dis. 2006 Sep 15; 194(6):760-3. PMID: 16941341.
    Citations: 4     Fields:    Translation:HumansCells
  101. Ojesina AI, Sankalé JL, Odaibo G, Langevin S, Meloni ST, Sarr AD, Olaleye D, Kanki PJ. Subtype-specific patterns in HIV Type 1 reverse transcriptase and protease in Oyo State, Nigeria: implications for drug resistance and host response. AIDS Res Hum Retroviruses. 2006 Aug; 22(8):770-9. PMID: 16910833.
    Citations: 16     Fields:    Translation:HumansCells
  102. MacNeil A, Sankalé JL, Meloni ST, Sarr AD, Mboup S, Kanki P. Genomic sites of human immunodeficiency virus type 2 (HIV-2) integration: similarities to HIV-1 in vitro and possible differences in vivo. J Virol. 2006 Aug; 80(15):7316-21. PMID: 16840312.
    Citations: 16     Fields:    Translation:HumansCells
  103. Sankalé JL, Tong Q, Hadigan CM, Tan G, Grinspoon SK, Kanki PJ, Hotamisligil GS. Regulation of adiponectin in adipocytes upon exposure to HIV-1. HIV Med. 2006 May; 7(4):268-74. PMID: 16630040.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  104. Sagay AS, Musa J, Adewole AS, Imade GE, Ekwempu CC, Kapiga S, Sankale JL, Idoko J, Kanki P. Rapid HIV testing and counselling in labour in a northern Nigerian setting. Afr J Reprod Health. 2006 Apr; 10(1):76-80. PMID: 16999197.
    Citations: 3     Fields:    Translation:Humans
  105. Odunukwe N, Idigbe O, Kanki P, Adewole T, Onwujekwe D, Audu R, Onyewuche J. Haematological and biochemical response to treatment of HIV-1 infection with a combination of nevirapine + stavudine + lamivudine in Lagos Nigeria. Turk J Haematol. 2005 Sep 05; 22(3):125-31. PMID: 27264834.
    Citations: 2     Fields:    
  106. Hanson A, Sarr AD, Shea A, Jones N, Mboup S, Kanki P, Cao H. Distinct profile of T cell activation in HIV type 2 compared to HIV type 1 infection: differential mechanism for immunoprotection. AIDS Res Hum Retroviruses. 2005 Sep; 21(9):791-8. PMID: 16218803.
    Citations: 11     Fields:    Translation:HumansCells
  107. Idigbe EO, Adewole TA, Eisen G, Kanki P, Odunukwe NN, Onwujekwe DI, Audu RA, Araoyinbo ID, Onyewuche JI, Salu OB, Adedoyin JA, Musa AZ. Management of HIV-1 infection with a combination of nevirapine, stavudine, and lamivudine: a preliminary report on the Nigerian antiretroviral program. . 2005 Sep 01; 40(1):65-9. PMID: 16123684.
    Citations: 15     Translation:HumansCellsCTClinical Trials
  108. Sagay AS, Kapiga SH, Imade GE, Sankale JL, Idoko J, Kanki P. HIV infection among pregnant women in Nigeria. Int J Gynaecol Obstet. 2005 Jul; 90(1):61-7. PMID: 15907849.
    Citations: 11     Fields:    Translation:Humans
  109. Aina O, Dadik J, Charurat M, Amangaman P, Gurumdi S, Mang E, Guyit R, Lar N, Datong P, Daniyam C, Kanki P, Abimiku A. Reference values of CD4 T lymphocytes in human immunodeficiency virus-negative adult Nigerians. Clin Diagn Lab Immunol. 2005 Apr; 12(4):525-30. PMID: 15817761.
    Citations: 18     Fields:    Translation:HumansCellsPHPublic Health
  110. Sarr AD, Eisen G, Guèye-Ndiaye A, Mullins C, Traoré I, Dia MC, Sankalé JL, Faye D, Mboup S, Kanki P. Viral dynamics of primary HIV-1 infection in Senegal, West Africa. J Infect Dis. 2005 May 01; 191(9):1460-7. PMID: 15809904.
    Citations: 8     Fields:    Translation:HumansCells
  111. Imade GE, Badung B, Pam S, Agbaji O, Egah D, Sagay AS, Sankalé JL, Kapiga S, Idoko J, Kanki P. Comparison of a new, affordable flow cytometric method and the manual magnetic bead technique for CD4 T-lymphocyte counting in a northern Nigerian setting. Clin Diagn Lab Immunol. 2005 Jan; 12(1):224-7. PMID: 15643012.
    Citations: 6     Fields:    Translation:Humans
  112. Meloni ST, Kim B, Sankalé JL, Hamel DJ, Tovanabutra S, Mboup S, McCutchan FE, Kanki PJ. Distinct human immunodeficiency virus type 1 subtype A virus circulating in West Africa: sub-subtype A3. J Virol. 2004 Nov; 78(22):12438-45. PMID: 15507630.
    Citations: 18     Fields:    Translation:HumansCells
  113. Meloni ST, Sankalé JL, Hamel DJ, Eisen G, Guéye-Ndiaye A, Mboup S, Kanki PJ. Molecular epidemiology of human immunodeficiency virus type 1 sub-subtype A3 in Senegal from 1988 to 2001. J Virol. 2004 Nov; 78(22):12455-61. PMID: 15507632.
    Citations: 8     Fields:    Translation:HumansCells
  114. McCutchan FE, Sankale JL, M'Boup S, Kim B, Tovanabutra S, Hamel DJ, Brodine SK, Kanki PJ, Birx DL. HIV type 1 circulating recombinant form CRF09_cpx from west Africa combines subtypes A, F, G, and may share ancestors with CRF02_AG and Z321. AIDS Res Hum Retroviruses. 2004 Aug; 20(8):819-26. PMID: 15320986.
    Citations: 4     Fields:    Translation:HumansCells
  115. Shea A, Sarr DA, Jones N, Penning L, Eisen G, Gueye-Ndiaye A, Mboup S, Kanki P, Cao H. CCR5 receptor expression is down-regulated in HIV type 2 infection: implication for viral control and protection. AIDS Res Hum Retroviruses. 2004 Jun; 20(6):630-5. PMID: 15242539.
    Citations: 2     Fields:    Translation:HumansCells
  116. Mullins C, Eisen G, Popper S, Dieng Sarr A, Sankale JL, Berger JJ, Wright SB, Chang HR, Coste G, Cooley TP, Rice P, Skolnik PR, Sullivan M, Kanki PJ. Highly active antiretroviral therapy and viral response in HIV type 2 infection. Clin Infect Dis. 2004 Jun 15; 38(12):1771-9. PMID: 15227626.
    Citations: 12     Fields:    Translation:HumansCells
  117. Tong Q, Sankalé JL, Hadigan CM, Tan G, Rosenberg ES, Kanki PJ, Grinspoon SK, Hotamisligil GS. Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices. J Clin Endocrinol Metab. 2003 Apr; 88(4):1559-64. PMID: 12679439.
    Citations: 23     Fields:    Translation:Humans
  118. Gilbert PB, McKeague IW, Eisen G, Mullins C, Guéye-NDiaye A, Mboup S, Kanki PJ. Comparison of HIV-1 and HIV-2 infectivity from a prospective cohort study in Senegal. Stat Med. 2003 Feb 28; 22(4):573-93. PMID: 12590415.
    Citations: 23     Fields:    Translation:HumansCells
  119. Mani I, Gilbert P, Sankalé JL, Eisen G, Mboup S, Kanki PJ. Intrapatient diversity and its correlation with viral setpoint in human immunodeficiency virus type 1 CRF02_A/G-IbNG infection. J Virol. 2002 Nov; 76(21):10745-55. PMID: 12368317.
    Citations: 21     Fields:    Translation:HumansCells
  120. Diouf K, Sarr AD, Eisen G, Popper S, Mboup S, Kanki P. Associations between MHC class I and susceptibility to HIV-2 disease progression. J Hum Virol. 2002 Jan-Feb; 5(1):1-7. PMID: 12352262.
    Citations: 5     Fields:    Translation:HumansCells
  121. Dieye TN, Sow PS, Simonart T, Guèye-Ndiaye A, Popper SJ, Delforge ML, Dieye A, Sarr AD, Crusiaux A, Van Vooren JP, Devleeschouwer M, Kanki P, Mboup S, Diakhate L, Farber CM. Immunologic and virologic response after tetanus toxoid booster among HIV-1- and HIV-2-infected Senegalese individuals. Vaccine. 2001 Dec 12; 20(5-6):905-13. PMID: 11738756.
    Citations: 7     Fields:    Translation:HumansCells
  122. McKeague IW, Gilbert PB, Kanki PJ. Omnibus tests for comparison of competing risks with adjustment for covariate effects. Biometrics. 2001 Sep; 57(3):818-28. PMID: 11550933.
    Citations:    Fields:    Translation:HumansCells
  123. Sarr AD, Lu Y, Sankalé JL, Eisen G, Popper S, Mboup S, Kanki PJ, Cao H. Robust HIV type 2 cellular immune response measured by a modified anthrax toxin-based enzyme-linked immunospot assay. AIDS Res Hum Retroviruses. 2001 Sep 01; 17(13):1257-64. PMID: 11559425.
    Citations: 5     Fields:    Translation:HumansCells
  124. Cao H, Mani I, Vincent R, Mugerwa R, Mugyenyi P, Kanki P, Ellner J, Walker BD. Cellular immunity to human immunodeficiency virus type 1 (HIV-1) clades: relevance to HIV-1 vaccine trials in Uganda. J Infect Dis. 2000 Nov; 182(5):1350-6. PMID: 11023458.
    Citations: 15     Fields:    Translation:HumansCellsCTClinical Trials
  125. Sturm-Ramirez K, Gaye-Diallo A, Eisen G, Mboup S, Kanki PJ. High levels of tumor necrosis factor-alpha and interleukin-1beta in bacterial vaginosis may increase susceptibility to human immunodeficiency virus. J Infect Dis. 2000 Aug; 182(2):467-73. PMID: 10915077.
    Citations: 40     Fields:    Translation:Humans
  126. Kokkotou EG, Sankale JL, Mani I, Gueye-Ndiaye A, Schwartz D, Essex ME, Mboup S, Kanki PJ. In vitro correlates of HIV-2-mediated HIV-1 protection. Proc Natl Acad Sci U S A. 2000 Jun 06; 97(12):6797-802. PMID: 10841574.
    Citations: 5     Fields:    Translation:HumansCells
  127. Sankalé JL, Hamel D, Woolsey A, Traoré T, Dia TC, Guèye-Ndiaye A, Essex M, Mboup T, Kanki P. Molecular evolution of human immunodeficiency virus type 1 subtype A in Senegal: 1988-1997. J Hum Virol. 2000 May-Jun; 3(3):157-64. PMID: 10881996.
    Citations: 9     Fields:    Translation:HumansCells
  128. Sarr AD, Sankalé JL, Hamel DJ, Travers KU, Guèye-Ndiaye A, Essex M, Mboup S, Kanki PJ. Interaction with human immunodeficiency virus (HIV) type 2 predicts HIV type 1 genotype. Virology. 2000 Mar 15; 268(2):402-10. PMID: 10704348.
    Citations: 4     Fields:    Translation:HumansCells
  129. Castillo RC, Arango-Jaramillo S, John R, Weinhold K, Kanki P, Carruth L, Schwartz DH. Resistance to human immunodeficiency virus type 1 in vitro as a surrogate of vaccine-induced protective immunity. J Infect Dis. 2000 Mar; 181(3):897-903. PMID: 10720510.
    Citations: 3     Fields:    Translation:HumansCells
  130. Malone JD, Sheffield J, Tribble D, Lowe-Bey F, Cannon M, Slaughter-Allen M, Brown AE, Kanki PJ. Evaluation of three rapid/simple tests for detection of HIV-2 antibodies. . 2000 Mar 01; 23(3):281-3. PMID: 10839666.
    Citations:    Translation:HumansCells
  131. Sarr AD, Sankalé JL, Guèye-Ndiaye A, Essex M, Mboup S, Kanki PJ. Genetic analysis of HIV type 2 in monotypic and dual HIV infections. AIDS Res Hum Retroviruses. 2000 Feb 10; 16(3):295-8. PMID: 10710218.
    Citations: 6     Fields:    Translation:HumansCells
  132. Leonard L, Ndiaye I, Kapadia A, Eisen G, Diop O, Mboup S, Kanki P. HIV prevention among male clients of female sex workers in Kaolack, Senegal: results of a peer education program. AIDS Educ Prev. 2000 Feb; 12(1):21-37. PMID: 10749384.
    Citations: 21     Fields:    Translation:Humans
  133. Popper SJ, Sarr AD, Guèye-Ndiaye A, Mboup S, Essex ME, Kanki PJ. Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo. J Virol. 2000 Feb; 74(3):1554-7. PMID: 10627569.
    Citations: 43     Fields:    Translation:HumansCells
  134. Sturm-Ramirez K, Brumblay H, Diop K, Guèye-Ndiaye A, Sankalé JL, Thior I, N'Doye I, Hsieh CC, Mboup S, Kanki PJ. Molecular epidemiology of genital Chlamydia trachomatis infection in high-risk women in Senegal, West Africa. J Clin Microbiol. 2000 Jan; 38(1):138-45. PMID: 10618077.
    Citations: 14     Fields:    Translation:HumansCells
  135. Mani I, Cao H, Hom D, Johnson JL, Mugerwa RD, Travers KU, Caliendo AM, Walker BD, Kanki PJ. Plasma RNA viral load as measured by the branched DNA and nucleic acid sequence-based amplification assays of HIV-1 subtypes A and D in Uganda. . 1999 Oct 01; 22(2):208-9. PMID: 10843537.
    Citations: 1     Translation:HumansCells
  136. Popper SJ, Sarr AD, Travers KU, Guèye-Ndiaye A, Mboup S, Essex ME, Kanki PJ. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2. J Infect Dis. 1999 Oct; 180(4):1116-21. PMID: 10479138.
    Citations: 62     Fields:    Translation:HumansCells
  137. Plantier JC, Damond F, Lasky M, Sankalé JL, Apetrei C, Peeters M, Buzelay L, M'Boup S, Kanki P, Delaporte E, Simon F, Barin F. V3 serotyping of HIV-1 infection: correlation with genotyping and limitations. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 15; 20(5):432-41. PMID: 10225224.
    Citations: 9     Fields:    Translation:HumansCells
  138. Kanki PJ, Hamel DJ, Sankalé JL, Hsieh Cc, Thior I, Barin F, Woodcock SA, Guèye-Ndiaye A, Zhang E, Montano M, Siby T, Marlink R, NDoye I, Essex ME, MBoup S. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis. 1999 Jan; 179(1):68-73. PMID: 9841824.
    Citations: 89     Fields:    Translation:HumansCells
  139. Sarr AD, Popper S, Thior I, Hamel DJ, Sankalé JL, Siby T, Marlink R, Essex M, Mboup S, Kanki P. Relation between HIV-2 proviral load and CD4+ lymphocyte count differs in monotypic and dual HIV infections. J Hum Virol. 1999 Jan-Feb; 2(1):45-51. PMID: 10200599.
    Citations: 7     Fields:    Translation:HumansCells
  140. Clark NM, Dieng Sarr A, Sankalé JL, Kanki PJ, Kazanjian P, Winfield R, Markovitz DM. Immunologic and virologic response of HIV-2 infection to antiretroviral therapy. AIDS. 1998 Dec 24; 12(18):2506-7. PMID: 9875594.
    Citations: 2     Fields:    Translation:HumansCells
  141. Sankalé JL, Mboup S, Essex ME, Kanki PJ. Genetic characterization of viral quasispecies in blood and cervical secretions of HIV-1- and HIV-2-infected women. AIDS Res Hum Retroviruses. 1998 Nov 01; 14(16):1473-81. PMID: 9824325.
    Citations: 4     Fields:    Translation:HumansCells
  142. Kokkotou E, Philippon V, Guèye-Ndiaye A, Mboup S, Wang WK, Essex M, Kanki P. Role of the CCR5 delta 32 allele in resistance to HIV-1 infection in west Africa. J Hum Virol. 1998 Nov-Dec; 1(7):469-74. PMID: 10195268.
    Citations: 2     Fields:    Translation:HumansCells
  143. Popper SJ, Sankalé JL, Thior I, Siby T, Marlink RG, Mboup S, Essex M, Kanki PJ. Antibodies to the HIV type 2 core protein p26 and Vpx: association with disease progression. AIDS Res Hum Retroviruses. 1998 Sep 01; 14(13):1157-62. PMID: 9737587.
    Citations:    Fields:    Translation:HumansCells
  144. Sarr AD, Hamel DJ, Thior I, Kokkotou E, Sankalé JL, Marlink RG, Coll-Seck EM, Essex ME, Siby T, NDoye I, Mboup S, Kanki PJ. HIV-1 and HIV-2 dual infection: lack of HIV-2 provirus correlates with low CD4+ lymphocyte counts. AIDS. 1998 Jan 22; 12(2):131-7. PMID: 9468361.
    Citations: 8     Fields:    Translation:HumansCells
  145. Travers KU, Eisen GE, Marlink RG, Essex ME, Hsieh CC, Mboup S, Kanki PJ. Protection from HIV-1 infection by HIV-2. AIDS. 1998 Jan 22; 12(2):224-5. PMID: 9468377.
    Citations: 4     Fields:    Translation:HumansCells
  146. Cao H, Kanki P, Sankalé JL, Dieng-Sarr A, Mazzara GP, Kalams SA, Korber B, Mboup S, Walker BD. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development. J Virol. 1997 Nov; 71(11):8615-23. PMID: 9343219.
    Citations: 33     Fields:    Translation:HumansCells
  147. Thior I, Diouf G, Diaw IK, Sarr AD, Hsieh CC, Ndoye I, Mboup S, Chen L, Essex M, Marlink R, Kanki P. Sexually transmitted diseases and risk of HIV infection in men attending a sexually transmitted diseases clinic in Dakar, Senegal. Afr J Reprod Health. 1997 Sep; 1(2):26-35. PMID: 10214412.
    Citations: 4     Fields:    Translation:Humans
  148. Kanki PJ, Peeters M, Guéye-Ndiaye A. Virology of HIV-1 and HIV-2: implications for Africa. AIDS. 1997; 11 Suppl B:S33-42. PMID: 9416365.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  149. Sankalé JL, De La Tour RS, Marlink RG, Scheib R, Mboup S, Essex ME, Kanki PJ. Distinct quasi-species in the blood and the brain of an HIV-2-infected individual. Virology. 1996 Dec 15; 226(2):418-23. PMID: 8955063.
    Citations: 4     Fields:    Translation:HumansCells
  150. Kanki PJ, Eisen G, Travers KU, Marlink RG, Essex ME, Hsieh CC, Mboup S. Response: HIV-2 and Natural Protection Against HIV-1 Infection. Science. 1996 Jun 28; 272(5270):1959b-60b. PMID: 17774134.
    Citations: 1     Fields:    
  151. Erdman SE, Kanki PJ, Moore FM, Brown SA, Kawasaki TA, Mikule KW, Travers KU, Badylak SF, Fox JG. Clusters of lymphoma in ferrets. Cancer Invest. 1996; 14(3):225-30. PMID: 8630683.
    Citations: 2     Fields:    Translation:AnimalsCellsPHPublic Health
  152. Sankalé JL, de la Tour RS, Renjifo B, Siby T, Mboup S, Marlink RG, Essex ME, Kanki PJ. Intrapatient variability of the human immunodeficiency virus type 2 envelope V3 loop. AIDS Res Hum Retroviruses. 1995 May; 11(5):617-23. PMID: 7576918.
    Citations: 4     Fields:    Translation:HumansCells
  153. Erdman SE, Reimann KA, Moore FM, Kanki PJ, Yu QC, Fox JG. Transmission of a chronic lymphoproliferative syndrome in ferrets. Lab Invest. 1995 May; 72(5):539-46. PMID: 7538182.
    Citations: 2     Fields:    Translation:AnimalsCells
  154. Marlink R, Kanki P, Thior I, Travers K, Eisen G, Siby T, Traore I, Hsieh CC, Dia MC, Gueye EH, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science. 1994 Sep 09; 265(5178):1587-90. PMID: 7915856.
    Citations: 131     Fields:    Translation:HumansCells
  155. Kanki PJ, Travers KU, MBoup S, Hsieh CC, Marlink RG, Gueye-NDiaye A, Siby T, Thior I, Hernandez-Avila M, Sankalé JL, et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet. 1994 Apr 16; 343(8903):943-6. PMID: 7909009.
    Citations: 80     Fields:    Translation:HumansCells
  156. Chen YM, Jang YJ, Kanki PJ, Yu QC, Wang JJ, Montali RJ, Samuel KP, Papas TS. Isolation and characterization of simian T-cell leukemia virus type II from New World monkeys. J Virol. 1994 Feb; 68(2):1149-57. PMID: 7507178.
    Citations: 8     Fields:    Translation:AnimalsCells
  157. Kane F, Alary M, Ndoye I, Coll AM, M'boup S, Guèye A, Kanki PJ, Joly JR. Temporary expatriation is related to HIV-1 infection in rural Senegal. AIDS. 1993 Sep; 7(9):1261-5. PMID: 8216985.
    Citations: 10     Fields:    Translation:Humans
  158. Kashala O, Kayembe K, Kanki P, Mukeba P, Diese M, Kalengayi M, Izzia KW, Essex M. Humoral aspects of anti-HIV immune responses in Zairians with AIDS: lower antigenemia does not correlate with immune complex levels. AIDS Res Hum Retroviruses. 1993 Mar; 9(3):251-8. PMID: 8471316.
    Citations: 1     Fields:    Translation:Humans
  159. Donnelly C, Leisenring W, Kanki P, Awerbuch T, Sandberg S. Comparison of transmission rates of HIV-1 and HIV-2 in a cohort of prostitutes in Senegal. Bull Math Biol. 1993; 55(4):731-43. PMID: 8318928.
    Citations: 12     Fields:    Translation:HumansCells
  160. Kanki P, M'Boup S, Marlink R, Travers K, Hsieh CC, Gueye A, Boye C, Sankalé JL, Donnelly C, Leisenring W, et al. Prevalence and risk determinants of human immunodeficiency virus type 2 (HIV-2) and human immunodeficiency virus type 1 (HIV-1) in west African female prostitutes. Am J Epidemiol. 1992 Oct 01; 136(7):895-907. PMID: 1442755.
    Citations: 24     Fields:    Translation:HumansCells
  161. Baillou A, Janvier B, Mayer R, Kanki P, M'Boup S, Denis F, Goudeau A, Essex M, Barin F. Site-directed serology using synthetic oligopeptides representing the C-terminus of the external glycoproteins of HIV-1, HIV-2, or SIVmac may distinguish subtypes among primate lentiviruses. AIDS Res Hum Retroviruses. 1991 Sep; 7(9):767-71. PMID: 1720632.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  162. M'Boup S, Kanki PJ, Mhalu FS. Laboratory diagnosis of HIV-1 and HIV-2 in Africa. AIDS. 1991; 5 Suppl 1:S93-101. PMID: 1669930.
    Citations: 1     Fields:    Translation:HumansCells
  163. Kanki PJ. Biologic features of HIV-2. An update. AIDS Clin Rev. 1991; 17-38. PMID: 1868007.
    Citations: 6     Fields:    Translation:HumansCells
  164. Essex M, Kanki PJ, Marlink R, Chou MJ, Lee TH. Antigenic characterization of the human immunodeficiency viruses. J Am Acad Dermatol. 1990 Jun; 22(6 Pt 2):1206-10. PMID: 2193947.
    Citations:    Fields:    Translation:HumansCells
  165. Zuber M, Samuel KP, Lautenberger JA, Kanki PJ, Papas TS. Bacterially produced HIV-2 env polypeptides specific for distinguishing HIV-2 from HIV-1 infections. AIDS Res Hum Retroviruses. 1990 Apr; 6(4):525-34. PMID: 2187502.
    Citations: 2     Fields:    Translation:HumansCells
  166. Romieu I, Marlink R, Kanki P, M'Boup S, Essex M. HIV-2 link to AIDS in West Africa. J Acquir Immune Defic Syndr (1988). 1990; 3(3):220-30. PMID: 2406413.
    Citations: 11     Translation:HumansCells
  167. Fincham JE, Van der Riet F, Steytler JG, Tung MT, Cooper R, Seier JV, Madden DL, Kanki P, Campbell JA, Taljaard JJ, et al. Increased peripheral lymphocytes, lymphoid hepatitis and anaemia in African vervet monkeys seropositive to retroviruses. J Comp Pathol. 1989 Jul; 101(1):53-68. PMID: 2551937.
    Citations:    Fields:    Translation:AnimalsCells
  168. Ayanian JZ, Maguire JH, Marlink RG, Essex M, Kanki PJ. HIV-2 infection in the United States. N Engl J Med. 1989 May 25; 320(21):1422-3. PMID: 2716792.
    Citations: 2     Fields:    Translation:HumansCells
  169. Kanki PJ. Clinical significance of HIV-2 infection in West Africa. AIDS Clin Rev. 1989; 95-108. PMID: 2577365.
    Citations: 7     Fields:    Translation:HumansCells
  170. Essex M, Kanki PJ. The origins of the AIDS virus. Sci Am. 1988 Oct; 259(4):64-71. PMID: 2907683.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  171. Hoxie JA, Haggarty BS, Bonser SE, Rackowski JL, Shan H, Kanki PJ. Biological characterization of a simian immunodeficiency virus-like retrovirus (HTLV-IV): evidence for CD4-associated molecules required for infection. J Virol. 1988 Aug; 62(8):2557-68. PMID: 2839686.
    Citations: 40     Fields:    Translation:HumansAnimalsCells
  172. Franchini G, Kanki PJ, Bosch ML, Fargnoli K, Wong-Staal F. The simian immunodeficiency virus envelope open reading frame located after the termination codon is expressed in vivo in infected animals. AIDS Res Hum Retroviruses. 1988 Aug; 4(4):251-8. PMID: 3144995.
    Citations: 3     Fields:    Translation:HumansAnimalsCells
  173. Kanki PJ, Essex M. Simian T-lymphotropic viruses and related human viruses. Vet Microbiol. 1988 Jul; 17(3):309-14. PMID: 2847395.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  174. Varnier OE, Lillo FB, Schito GC, Lazzarin A, Kanki PJ. Parallel Western blot analysis for HIV-1 and HIV-2 antibodies: absence of HIV-2 infection in Italian subjects at risk for AIDS. AIDS. 1988 Jun; 2(3):215-7. PMID: 3134917.
    Citations: 3     Fields:    Translation:HumansCells
  175. Marlink RG, Ricard D, M'Boup S, Kanki PJ, Romet-Lemonne JL, N'Doye I, Diop K, Simpson MA, Greco F, Chou MJ, et al. Clinical, hematologic, and immunologic cross-sectional evaluation of individuals exposed to human immunodeficiency virus type-2 (HIV-2). AIDS Res Hum Retroviruses. 1988 Apr; 4(2):137-48. PMID: 3259142.
    Citations: 32     Fields:    Translation:HumansCells
  176. Van der Riet FS, Human PA, Cooper DK, Reichart B, Fincham JE, Kalter SS, Kanki PJ, Essex M, Madden DL, Lai-Tung MT, et al. Virological implications of the use of primates in xenotransplantation. Transplant Proc. 1987 Oct; 19(5):4068-9. PMID: 2823433.
    Citations: 3     Fields:    Translation:HumansAnimalsCells
  177. Kanki PJ. West African human retroviruses related to STLV-III. AIDS. 1987 Sep; 1(3):141-5. PMID: 3126753.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  178. Barin F, Denis F, Baillou A, Leonard G, Mounier M, M'Boup S, Gershy-Damet G, Sangare A, Kanki P, Essex M. A STLV-III related human retrovirus, HTLV-IV: analysis of cross-reactivity with the human immunodeficiency virus (HIV). J Virol Methods. 1987 Aug; 17(1-2):55-61. PMID: 2444614.
    Citations: 2     Fields:    Translation:HumansCells
  179. Arya SK, Beaver B, Jagodzinski L, Ensoli B, Kanki PJ, Albert J, Fenyo EM, Biberfeld G, Zagury JF, Laure F, et al. New human and simian HIV-related retroviruses possess functional transactivator (tat) gene. Nature. 1987 Aug 6-12; 328(6130):548-50. PMID: 3039372.
    Citations: 35     Fields:    Translation:HumansAnimalsCells
  180. Kanki PJ, M'Boup S, Ricard D, Barin F, Denis F, Boye C, Sangare L, Travers K, Albaum M, Marlink R, et al. Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa. Science. 1987 May 15; 236(4803):827-31. PMID: 3033826.
    Citations: 24     Fields:    Translation:HumansCells
  181. Kanki PJ, Barin F, M'Boup S, Essex M. Relationship of simian T-lymphotropic virus type III to human retroviruses in Africa. Antibiot Chemother (1971). 1987; 38:21-7. PMID: 2889421.
    Citations:    Fields:    Translation:HumansAnimalsCells
  182. Franchini G, Collalti E, Arya SK, Fenyö EM, Biberfeld G, Zagury JF, Kanki PJ, Wong-Staal F, Gallo RC. Genetic analysis of a new subgroup of human and simian T-lymphotropic retroviruses: HTLV-IV, LAV-2, SBL-6669, and STLV-IIIAGM. AIDS Res Hum Retroviruses. 1987; 3(1):11-7. PMID: 3040052.
    Citations: 8     Fields:    Translation:HumansAnimalsCells
  183. Kanki PJ, Hopper JR, Essex M. The origins of HIV-1 and HTLV-4/HIV-2. Ann N Y Acad Sci. 1987; 511:370-5. PMID: 2894192.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  184. Kanki PJ, Allan J, Barin F, Redfield R, Clumeck N, Quinn T, Mowovondi F, Thiry L, Burny A, Zagury D, et al. Absence of antibodies to HIV-2/HTLV-4 in six central African nations. AIDS Res Hum Retroviruses. 1987; 3(3):317-22. PMID: 2893632.
    Citations: 1     Fields:    Translation:HumansCells
  185. Allan JS, Coligan JE, Lee TH, Barin F, Kanki PJ, M'Boup S, McLane MF, Groopman JE, Essex M. Immunogenic nature of a Pol gene product of HTLV-III/LAV. Blood. 1987 Jan; 69(1):331-3. PMID: 3024760.
    Citations: 12     Fields:    Translation:HumansCells
  186. Hirsch V, Riedel N, Kornfeld H, Kanki PJ, Essex M, Mullins JI. Cross-reactivity to human T-lymphotropic virus type III/lymphadenopathy-associated virus and molecular cloning of simian T-cell lymphotropic virus type III from African green monkeys. Proc Natl Acad Sci U S A. 1986 Dec; 83(24):9754-8. PMID: 3491989.
    Citations: 9     Fields:    Translation:AnimalsCells
  187. Kanki PJ, Barin F, M'Boup S, Allan JS, Romet-Lemonne JL, Marlink R, McLane MF, Lee TH, Arbeille B, Denis F, et al. New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM). Science. 1986 Apr 11; 232(4747):238-43. PMID: 3006256.
    Citations: 39     Fields:    Translation:HumansAnimalsCells
  188. Barin F, M'Boup S, Denis F, Kanki P, Allan JS, Lee TH, Essex M. Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa. Lancet. 1985 Dec 21-28; 2(8469-70):1387-9. PMID: 2867393.
    Citations: 38     Fields:    Translation:HumansAnimalsCells
  189. Kanki PJ, Alroy J, Essex M. Isolation of T-lymphotropic retrovirus related to HTLV-III/LAV from wild-caught African green monkeys. Science. 1985 Nov 22; 230(4728):951-4. PMID: 2997923.
    Citations: 35     Fields:    Translation:AnimalsCells
  190. Allan JS, Coligan JE, Lee TH, McLane MF, Kanki PJ, Groopman JE, Essex M. A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. Science. 1985 Nov 15; 230(4727):810-3. PMID: 2997921.
    Citations: 52     Fields:    Translation:HumansAnimalsCells
  191. Essex M, Allan J, Kanki P, McLane MF, Malone G, Kitchen L, Lee TH. Antigens of human T-lymphotropic virus type III/lymphadenopathy-associated virus. Ann Intern Med. 1985 Nov; 103(5):700-3. PMID: 2996402.
    Citations: 11     Fields:    Translation:HumansAnimalsCells
  192. Essex M, McLane MF, Kanki P, Allan J, Kitchen L, Lee TH. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings. Cancer Res. 1985 Sep; 45(9 Suppl):4534s-4538s. PMID: 2990682.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  193. Kanki PJ, Kurth R, Becker W, Dreesman G, McLane MF, Essex M. Antibodies to simian T-lymphotropic retrovirus type III in African green monkeys and recognition of STLV-III viral proteins by AIDS and related sera. Lancet. 1985 Jun 08; 1(8441):1330-2. PMID: 2860515.
    Citations: 24     Fields:    Translation:HumansAnimalsCells
  194. Kanki PJ, McLane MF, King NW, Letvin NL, Hunt RD, Sehgal P, Daniel MD, Desrosiers RC, Essex M. Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III. Science. 1985 Jun 07; 228(4704):1199-201. PMID: 3873705.
    Citations: 68     Fields:    Translation:AnimalsCells
  195. Daniel MD, Letvin NL, King NW, Kannagi M, Sehgal PK, Hunt RD, Kanki PJ, Essex M, Desrosiers RC. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science. 1985 Jun 07; 228(4704):1201-4. PMID: 3159089.
    Citations: 284     Fields:    Translation:AnimalsCells
  196. Lee TH, Kanki P, McLane MF, Tachibana N, Essex M. Pathobiology of human T-cell leukemia virus. Prog Clin Biol Res. 1985; 182:213-21. PMID: 2994099.
    Citations:    Fields:    Translation:HumansCells
  197. Kanki PJ, Homma T, Lee TH, King NW, Hunt RD, Essex M. Antibodies to human T-cell leukemia virus-membrane antigens in macaques with malignant lymphoma. Haematol Blood Transfus. 1985; 29:345-9. PMID: 2993131.
    Citations: 1     Fields:    Translation: